New Jersey joined two amicus briefs this week supporting the Food and Drug Administration in the U.S. Supreme Court case of FDA v. Alliance for Hippocratic Medicine, in which the court granted petitions for review a Fifth Circuit opinion restricting distribution of the medication mifepristone. The underlying dispute centers around a lawsuit filed by the anti-abortion group Alliance for Hippocratic Medicine, which claimed that the FDA’s original approval of the drug in 2000, and subsequent actions expanding access to the drug, were illegal. The Reproductive Freedom Alliance filed a separate amicus curiae brief with the U.S. Supreme Court in the same case, arguing that if the court allows the recent Fifth Circuit decision to stand, it could undermine the ability of governors to provide adequate health care services. The Reproductive Freedom Alliance is represented in the matter by Jamie Santos, lead counsel and co-chair of the Appellate and Supreme Court Litigation practice. More in Law.com.